Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Shares were up after the ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday, February 12. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Humana will make investments to improve its Medicare Advantage Star Ratings, Chief Financial Officer Celeste Mellet said.
The U.S. Department of Labor alleged wrongful denials for ER and urinary drug screening; Eden Prairie-based company says processes are no longer in place.
MetLife Inc. Floating Rate Non-Cum. Pfd. Series A 0.04% ...